TLR4 c.150C>T ;(p.D50=)

Variant ID: 9-120470897-C-T

NM_138554.4(TLR4):c.150C>T;(p.D50=)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach.

International Journal Of Nanomedicine
Naseer, Faiza F; Ahmad, Tahir T; Kousar, Kousain K; Kakar, Salik S; Gul, Rabia R; Anjum, Sadia S; Shareef, Usman U
Publication Date: 2023

Variant appearance in text: TLR4: D50=
PubMed Link: 36643861
Variant Present in the following documents:
  • Main text
  • ijn-18-185.pdf
View BVdb publication page



Durable natural killer cell responses after heterologous two-dose Ebola vaccination.

Npj Vaccines
Wagstaffe, Helen R HR; Susannini, Giada G; Thiébaut, Rodolphe R; Richert, Laura L; Lévy, Yves Y; Bockstal, Viki V; Stoop, Jeroen N JN; Luhn, Kerstin K; Douoguih, Macaya M; Riley, Eleanor M EM; Lacabaratz, Christine C; Goodier, Martin R MR
Publication Date: 2021-01-29

Variant appearance in text: TLR-4: D50D
PubMed Link: 33514756
Variant Present in the following documents:
  • Main text
View BVdb publication page